Antibody Engineering & Therapeutics Virtual 2020: Post-event Report - Antibody Engineering & Therapeutics Virtual: Post-event Report

Antibody Engineering & Therapeutics Virtual 2020: Post-event ReportIn this report, we look back at the Antibody Engineering & Therapeutics virtual conference in mid-December 2020.Contents

Introduction & Contents

Key Themes of the Week

Bispecific T Cell Engagers

Advancing Therapeutic Antibody Discovery Using RenMab / RenLite / RenMab KO Immunoglobulin Humanized Mouse Platforms

Antibody Affinity Maturation and Developability Improvement for Lead Optimization

RenMab Mouse: A Leading Platform for Fully Human Antibody Generation

The Antibody Society Student/PostDoc Poster Competition Winners

Novel TNFR2 humanized mouse model for in vivo validation of human TNFR2 antibody targeting hTNF /hTNFR2 signaling pathways

Join us at Antibodies, Next-Generation Proteins & Bioconjugates Digital Week